Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Correspondence

Correspondence to editorial on “Global epidemiology of alcohol-related liver disease, liver cancer, and alcohol use disorder, 2000-2021”

Pojsakorn Danpanichkul, Luis Antonio Diaz, Kanokphong Suparan, Karn Wijarnpreecha, Juan Pablo Arab

Clin Mol Hepatol. 2025;31(2):e200-e202. Published online February 17, 2025

DOI: https://doi.org/10.3350/cmh.2025.0166

View: 676 Download: 28

Addressing the burden of steatotic liver disease: The role of transient elastography: Correspondence to editorial on “Current burden of steatotic liver disease and fibrosis among adults in the United States, 2017-2023”

Donghee Kim, Pojsakorn Danpanichkul, Karn Wijarnpreecha, George Cholankeril, Rohit Loomba, Aijaz Ahmed

Clin Mol Hepatol. 2025;31(2):e180-e182. Published online February 13, 2025

DOI: https://doi.org/10.3350/cmh.2025.0125

View: 605 Download: 20

Letter to the Editor

Global inequality in the burden of hepatitis B from 1990 to 2021: Findings from the global burden of disease study 2021: Letter to the editor on “Comprehensive approach to controlling chronic hepatitis B in China”

Chunlong Liu, Jiangtao Yu

Clin Mol Hepatol. 2025;31(2):e134-e136. Published online December 17, 2024

DOI: https://doi.org/10.3350/cmh.2024.1085

View: 932 Download: 81

Original Article

Global epidemiology of alcohol-related liver disease, liver cancer, and alcohol use disorder, 2000–2021

Pojsakorn Danpanichkul, Luis Antonio Díaz, Kanokphong Suparan, Primrose Tothanarungroj, Supapitch Sirimangklanurak, Thanida Auttapracha, Hanna L. Blaney, Banthoon Sukphutanan, Yanfang Pang, Siwanart Kongarin, Francisco Idalsoaga, Eduardo Fuentes-López, Lorenzo Leggio, Mazen Noureddin, Trenton M. White, Alexandre Louvet, Philippe Mathurin, Rohit Loomba, Patrick S. Kamath, Jürgen Rehm, Jeffrey V. Lazarus, Karn Wijarnpreecha, Juan Pablo Arab

Clin Mol Hepatol. 2025;31(2):525-547. Published online January 9, 2025

DOI: https://doi.org/10.3350/cmh.2024.0835

View: 3376 Download: 275 Crossref: 5

Letter to the Editor

Letter to the editor on “Sorafenib vs. Lenvatinib in advanced hepatocellular carcinoma after atezolizumab/bevacizumab failure: A real-world study”

Meng-Che Wu, Hui-Chin Chang, Yi-Sheng Jhang, Shuo-Yan Gau

Clin Mol Hepatol. 2025;31(1):e13-e14. Published online September 2, 2024

DOI: https://doi.org/10.3350/cmh.2024.0682

View: 1243 Download: 102 Crossref: 1

Metabolic dysfunction-associated fatty liver disease related hepatocellular carcinoma in China: An increasing problem: Letter to the edior on “Global prevalence of metabolic dysfunction-associated fatty liver disease-related hepatocellular carcinoma: A systematic review and meta-analysis”

Xiangyu Wu, Wenjing Ni, Qianqian Chen, Junping Shi, Jie Li

Clin Mol Hepatol. 2024;30(4):965-969. Published online June 18, 2024

DOI: https://doi.org/10.3350/cmh.2024.0386

View: 2280 Download: 90

Original Article

Evolutionary changes in metabolic dysfunction-associated steatotic liver disease and risk of hepatocellular carcinoma: A nationwide cohort study

Seogsong Jeong, Yun Hwan Oh, Joseph C Ahn, Seulggie Choi, Sun Jae Park, Hye Jun Kim, Gyeongsil Lee, Joung Sik Son, Heejoon Jang, Dong Hyeon Lee, Meng Sha, Lei Chen, Won Kim, Sang Min Park

Clin Mol Hepatol. 2024;30(3):487-499. Published online May 7, 2024

DOI: https://doi.org/10.3350/cmh.2024.0145

View: 4475 Download: 286 Web of Science: 4 Crossref: 12

Global prevalence of metabolic dysfunction-associated fatty liver disease-related hepatocellular carcinoma: A systematic review and meta-analysis

Harry Crane, Guy D. Eslick, Cameron Gofton, Anjiya Shaikh, George Cholankeril, Mark Cheah, Jian-Hong Zhong, Gianluca Svegliati-Baroni, Alessandro Vitale, Beom Kyung Kim, Sang Hoon Ahn, Mi Na Kim, Simone I Strasser, Jacob George

Clin Mol Hepatol. 2024;30(3):436-448. Published online April 16, 2024

DOI: https://doi.org/10.3350/cmh.2024.0109

View: 7194 Download: 332 Web of Science: 15 Crossref: 16

Correspondence

In response to: Steatotic liver disease-know your enemies

Michael H. Le, Linda Henry, Mindie H. Nguyen

Clin Mol Hepatol. 2024;30(2):284-286. Published online February 19, 2024

DOI: https://doi.org/10.3350/cmh.2024.0108

View: 2553 Download: 48

Original Article

Global incidence of adverse clinical events in non-alcoholic fatty liver disease: A systematic review and meta-analysis

Michael H. Le, David M. Le, Thomas C. Baez, Hansen Dang, Vy H. Nguyen, KeeSeok Lee, Christopher D. Stave, Takanori Ito, Yuankai Wu, Yee Hui Yeo, Fanpu Ji, Ramsey Cheung, Mindie H. Nguyen

Clin Mol Hepatol. 2024;30(2):235-246. Published online January 26, 2024

DOI: https://doi.org/10.3350/cmh.2023.0485

View: 7780 Download: 317 Web of Science: 24 Crossref: 30

Review

Global incidence and prevalence of nonalcoholic fatty liver disease

Margaret LP Teng, Cheng Han Ng, Daniel Q. Huang, Kai En Chan, Darren JH Tan, Wen Hui Lim, Ju Dong Yang, Eunice Tan, Mark D. Muthiah

Clin Mol Hepatol. 2023;29(Suppl):S32-S42. Published online December 14, 2022

DOI: https://doi.org/10.3350/cmh.2022.0365

View: 19585 Download: 664 Web of Science: 266 Crossref: 304

Original Article

Differences in liver and mortality outcomes of non-alcoholic fatty liver disease by race and ethnicity: A longitudinal real-world study

Vy H. Nguyen, Isaac Le, Audrey Ha, Richard Hieu Le, Nicholas Ajit Rouillard, Ashley Fong, Surya Gudapati, Jung Eun Park, Mayumi Maeda, Scott Barnett, Ramsey Cheung, Mindie H. Nguyen

Clin Mol Hepatol. 2023;29(4):1002-1012. Published online September 11, 2023

DOI: https://doi.org/10.3350/cmh.2023.0205

View: 4090 Download: 138 Web of Science: 14 Crossref: 15

Editorial

The latest global burden of liver cancer: A past and present threat

Joo Hyun Oh, Dae Won Jun

Clin Mol Hepatol. 2023;29(2):355-357. Published online March 9, 2023

DOI: https://doi.org/10.3350/cmh.2023.0070

View: 7071 Download: 144 Web of Science: 57 Crossref: 61

The emerging age-pattern changes of patients with hepatocellular carcinoma in Korea

Yuri Cho, Bo Hyun Kim, Joong-Won Park

Clin Mol Hepatol. 2023;29(1):99-101. Published online October 27, 2022

DOI: https://doi.org/10.3350/cmh.2022.0321

View: 4528 Download: 90 Web of Science: 4 Crossref: 5

Original Article

Association of non-alcoholic fatty liver disease with incident dementia later in life among elder adults

Seogsong Jeong, Yun Hwan Oh, Seulggie Choi, Jooyoung Chang, Sung Min Kim, Joung Sik Son, Gyeongsil Lee, Joseph C Ahn, Dong Hyeon Lee, Bo Kyung Koo, Won Kim, Sang Min Park

Clin Mol Hepatol. 2022;28(3):510-521. Published online March 17, 2022

DOI: https://doi.org/10.3350/cmh.2021.0332

View: 8349 Download: 335 Web of Science: 34 Crossref: 36

Editorial

Association of nonalcoholic fatty liver disease with incident dementia later in life among elderly adults

Byoung Seok Ye

Clin Mol Hepatol. 2022;28(3):481-482. Published online May 16, 2022

DOI: https://doi.org/10.3350/cmh.2022.0097

View: 3756 Download: 87 Web of Science: 1 Crossref: 2

Guideline

KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease

Seong Hee Kang, Hye Won Lee, Jeong-Ju Yoo, Yuri Cho, Seung Up Kim, Tae Hee Lee, Byoung Kuk Jang, Sang Gyune Kim, Sang Bong Ahn, Haeryoung Kim, Dae Won Jun, Joon-Il Choi, Do Seon Song, Won Kim, Soung Won Jeong, Moon Young Kim, Hong Koh, Sujin Jeong, Jin-Woo Lee, Yong Kyun Cho, on behalf of The Korean Association for the Study of the Liver (KASL)

Clin Mol Hepatol. 2021;27(3):363-401. Published online June 22, 2021

DOI: https://doi.org/10.3350/cmh.2021.0178

View: 23813 Download: 1,273 Web of Science: 178 Crossref: 190

Editorial

Marta Tonon, Salvatore Piano

Clin Mol Hepatol. 2021;27(1):94-96. Published online December 3, 2020

DOI: https://doi.org/10.3350/cmh.2020.0305

View: 5623 Download: 149 Web of Science: 8 Crossref: 8

Review

Current understanding of primary biliary cholangitis

Atsushi Tanaka

Clin Mol Hepatol. 2021;27(1):1-21. Published online December 3, 2020

DOI: https://doi.org/10.3350/cmh.2020.0028

View: 17382 Download: 922 Web of Science: 82 Crossref: 91

Editorial

Long-term prognosis and management of hepatocellular carcinoma after curative treatment

Naoshi Nishida

Clin Mol Hepatol. 2020;26(4):480-483. Published online September 21, 2020

DOI: https://doi.org/10.3350/cmh.2020.0208

View: 6367 Download: 105 Web of Science: 14 Crossref: 13

Review

Epidemiology of alcoholic liver disease in Korea

Jae Young Jang, Dong Joon Kim

Clin Mol Hepatol. 2018;24(2):93-99. Published online March 16, 2018

DOI: https://doi.org/10.3350/cmh.2017.0079

View: 14038 Download: 275 Web of Science: 24 Crossref: 22

Epidemiology of liver cancer in South Korea

Bo Hyun Kim, Joong-Won Park

Clin Mol Hepatol. 2018;24(1):1-9. Published online December 18, 2017

DOI: https://doi.org/10.3350/cmh.2017.0112

View: 17074 Download: 507 Web of Science: 148 Crossref: 155

Original Article

Geographic differences in the epidemiological features of HCV infection in Korea

Kyung-Ah Kim, Sook-Hyang Jeong, Eun Sun Jang, Young Seok Kim, Youn Jae Lee, Eun Uk Jung, In Hee Kim, Sung Bum Cho, Mee-Kyung Kee, Chun Kang

Clin Mol Hepatol. 2014;20(4):361-367. Published online December 24, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.4.361

View: 8259 Download: 63 Web of Science: 6 Crossref: 12

Review

KASL clinical practice guidelines: Management of Hepatitis C

The Korean Association for the Study of the Liver (KASL)

Clin Mol Hepatol. 2014;20(2):89-136. Published online June 30, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.2.89

View: 26730 Download: 92 Web of Science: 25 Crossref: 30

Original Article

Clinical and epidemiological characteristics of Korean patients with hepatitis C virus genotype 6

Mun Hyuk Seong, Ho Kil, Jong Yeop Kim, Sang Soo Lee, Eun Sun Jang, Jin-Wook Kim, Sook-Hyang Jeong, Young Seok Kim, Si Hyun Bae, Youn Jae Lee, Han Chu Lee, Haesun Yun, Byung Hak Kang, Kisang Kim

Clin Mol Hepatol. 2013;19(1):45-50. Published online March 25, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.1.45

View: 8510 Download: 95 Crossref: 13

Review

Epidemiology and prevention of hepatitis B virus infection

So Young Kwon, Chang Hong Lee

Clin Mol Hepatol. 2011;17(2):87-95. Published online June 23, 2011

DOI: https://doi.org/10.3350/kjhep.2011.17.2.87

View: 15007 Download: 163 Crossref: 91

Original Article

A nationwide seroprevalence of total antibody to hepatitis A virus from 2005 to 2009: age and area-adjusted prevalence rates

Donghun Lee, Moran Ki, Anna Lee, Kyoung-Ryul Lee, Hee Bong Park, Chang Sub Kim, Bo Young Yoon, Jong Hyun Kim, Young Sok Lee, Sook-Hyang Jeong

Clin Mol Hepatol. 2011;17(1):44-50. Published online March 21, 2011

DOI: https://doi.org/10.3350/kjhep.2011.17.1.44

View: 7498 Download: 63 Crossref: 17

Current status of Liver diseases in Korea: Liver cirrhosis

Jeong Won Jang

Clin Mol Hepatol. 2009;15(60):40-49. Published online December 31, 2009

DOI: https://doi.org/10.3350/kjhep.2009.15.S6.S40

View: 7453 Download: 128 Crossref: 24

Current status of Liver diseases in Korea: Toxic and alcoholic Liver diseases

Kyung Ah Kim

Clin Mol Hepatol. 2009;15(60):29-33. Published online December 31, 2009

DOI: https://doi.org/10.3350/kjhep.2009.15.S6.S29

View: 5814 Download: 62 Crossref: 12

Current status of Liver diseases in Korea: Hepatitis C

Young Suk Lim

Clin Mol Hepatol. 2009;15(60):25-28. Published online December 31, 2009

DOI: https://doi.org/10.3350/kjhep.2009.15.S6.S25

View: 6584 Download: 27 Crossref: 20

1 | 2 |

Viewed By 9996	Epidemiology of metabolic dysfunction-associated steatotic liver disease
Viewed By 7136	MAFLD: How is it different from NAFLD?
Viewed By 5122	Global incidence and prevalence of nonalcoholic fatty liver disease
Viewed By 4655	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4609	Hepatocellular carcinoma: updates on epidemiology, surveillance, diagnosis and treatment

Cited By 322	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 304	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 205	MAFLD: How is it different from NAFLD?
Cited By 104	Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis
Cited By 103	Non-alcoholic fatty liver disease: Definition and subtypes

Search